Journal of Market Access & Health Policy

MDPI AG

Journal websitePeer review: Double-blind review
Evaluation status available after sign-in

About the journal

Journal of Market Access & Health Policy is an open-access journal published by MDPI AG in Switzerland, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 1,500 CHF. Declared review time at DOAJ: 6 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
MDPI AG
ISSN
2001-6689
Country
Switzerland
Languages
english
Access
Open access
Declared publication charge
1,500 CHF
Articles in DOAJ
297
Declared review time
6 weeks
Declared peer-review model
double_blind

Index listings

  • DOAJ · 2013-09-13
  • PUBMED · 2020-06-17
Indexing
DOAJ · PUBMED
APC
1,500 CHF
Declared review time (DOAJ)
6 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

297

Most recent article

4 months ago

Average review time (journal-declared via DOAJ)

6weeks

Works in OpenAlex

357

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

37

i10-index

128

From OpenAlex open data (CC0).

Editorial & policy13
Last DOAJ review date
2025-02-27
Added to DOAJ
2013-09-13
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSPMC
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
99%
ORCID iDs in current deposits
88%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity3
Alternate titles
Journal of market access and health policyJMAHP
Source type
journal
NLM unique ID (PubMed)
101670174
Classification4

Subjects (DOAJ)

Medicine: Public aspects of medicineSocial Sciences: Commerce: Business

LCC codes

RA1-1270HF5001-6182

Subject areas

  • Health Systems, Economic Evaluations, Quality of Life
  • Health Systems, Economic Evaluations, Quality of Life
  • Pharmaceutical Economics and Policy
  • Pharmaceutical Economics and Policy
  • Biomedical Ethics and Regulation
  • Economic and Financial Impacts of Cancer
  • Economic and Financial Impacts of Cancer
  • Biomedical Ethics and Regulation
Show all subjects (50)
  • Healthcare Policy and Management
  • Healthcare cost, quality, practices
  • Pharmaceutical studies and practices
  • Healthcare cost, quality, practices
  • Healthcare Policy and Management
  • Vaccine Coverage and Hesitancy
  • Pharmaceutical studies and practices
  • Vaccine Coverage and Hesitancy
  • Pharmaceutical industry and healthcare
  • Pharmaceutical industry and healthcare
  • Biosimilars and Bioanalytical Methods
  • Biosimilars and Bioanalytical Methods
  • Global Health Care Issues
  • Global Health Care Issues
  • Healthcare Systems and Reforms
  • Healthcare Systems and Reforms
  • CAR-T cell therapy research
  • CAR-T cell therapy research
  • Viral gastroenteritis research and epidemiology
  • Clinical practice guidelines implementation
  • Viral gastroenteritis research and epidemiology
  • Schizophrenia research and treatment
  • COVID-19 Clinical Research Studies
  • Clinical practice guidelines implementation
  • Quality and Safety in Healthcare
  • Schizophrenia research and treatment
  • COVID-19 Clinical Research Studies
  • Quality and Safety in Healthcare
  • Mental Health and Psychiatry
  • Atrial Fibrillation Management and Outcomes
  • Hepatitis Viruses Studies and Epidemiology
  • Atrial Fibrillation Management and Outcomes
  • Primary Care and Health Outcomes
  • Mental Health and Psychiatry
  • Primary Care and Health Outcomes
  • Hepatitis Viruses Studies and Epidemiology
  • Medication Adherence and Compliance
  • Statistical Methods in Clinical Trials
  • Medication Adherence and Compliance
  • SARS-CoV-2 and COVID-19 Research
  • SARS-CoV-2 and COVID-19 Research
  • Statistical Methods in Clinical Trials

Keywords (DOAJ)

  • health technology
  • health policy
  • health economics
  • public health

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: